While some studies did not find differences in the percentage of IL-4-producing CD4+ cells (considered as Th2 cells) in the peripheral blood of NASH patients compared to control subjects [83,85], other studies found a greater percentage of these circulating cells in both NAFL and NASH patients compared to healthy volunteers [20,82]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.